{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-26-007137","form_type":"8-K","ticker":"DMII","cik":"0002040475","company_name":"Drugs Made In America Acquisition II Corp.","filed_at":"2026-11-18T16:08:56+00:00","discovered_at":"2026-11-18T16:10:01.792160+00:00","generated_at":"2026-11-18T16:10:07.289373+00:00","sec_items":["2.03","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"DMII proposes $600M combination with Alpha AI Biotech paid in 60M shares at $10.00","bullets":["Preliminary, nonbinding proposal values Alpha AI Biotech Group at $600 million pre-money, payable in 60,000,000 ordinary shares at $10.00 per share.","Up to 30,000,000 additional earn-out shares in two equal tranches tied to share-price thresholds of $12.50 and $15.00 during 24 months after closing.","Board approved a 30-day limited standstill expiring on or about December 3, 2026; no definitive agreement, due diligence and audited financials still pending.","Investor Tal Alpha funded $250,000 on November 6, 2026; notes consolidated into a $700,000 convertible note maturing June 30, 2027, convertible at a 35% discount; $700,000 remains available.","Alon Izidor Tal, CEO of the Investor, is also an Alpha director and acknowledged the proposal on Alpha's behalf."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-26-007137","json":"https://secwatch.observer/filing/0001477932-26-007137.json","markdown":"https://secwatch.observer/filing/0001477932-26-007137.md","text":"https://secwatch.observer/filing/0001477932-26-007137.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2040475/000147793226007137/0001477932-26-007137-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2040475/000147793226007137/dmiiu_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-11-18T16:10:07.289373+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}